使用细针光声探针对前列腺癌结构异质性进行间质评估
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.
研究概览
详细说明
14AUG2024- enrollment was increased to 50 subjects
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Cancer AnswerLine
- 电话号码:1-800-865-1125
- 邮箱:CancerAnswerLine@med.umich.edu
学习地点
-
-
Michigan
-
Ann Arbor、Michigan、美国、48109
- 招聘中
- University of Michigan Rogel Cancer Center
-
接触:
- Cancer AnswerLine
- 电话号码:800-865-1125
- 邮箱:CancerAnswerLine@med.umich.edu
-
首席研究员:
- Guan Xu, Phd
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients with planned prostate biopsy procedures will be recruited through U-M Urology Clinics
描述
Inclusion Criteria:
- 1) Planned prostate biopsy as part of routine clinical care
- 2) > 40 and <80 years old
Exclusion Criteria:
- 1) Known history of bleeding disorders or
- 2) Patients taking anticoagulants, no matter doses or washout time
- 3) Known allergy to silicone material
- 4) Unable to provide informed consent
- 5) Either the surgeon or the patient do not think the patient will not be able to complete all parts of the study, the patient will be excluded
- 6) Involved in other investigational studies.
学习计划
研究是如何设计的?
设计细节
- 观测模型:OTHER
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Biopsy
Patients will be identified once prostate biopsies have been scheduled. Once enrolled on trial, patients will undergo standard biopsy procedure as per clinical care. During this biopsy, research measurements will be completed using the fine needle photoacoustic probe. |
Fine Needle Photoacoustic Probe guided by the standard biopsy system without tissue core extraction |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Demonstration of reliable measurements
大体时间:day 1
|
The primary aim of this study is to demonstrate that our fine needle PA probe can acquire reliable measurements of prostate glands. This will be indicated by a signal-to-noise ratio of the measurements that is larger than one. We will calculate the signal to noise ratio of the signals as the peak-to-peak signal magnitude over the amplitude of the system background signal. The technical failure is that we will not be able to achieve measurements with signal-to-noise ratios larger than 1 in 10% of the measurements. We will have a futility analysis after first 5 patients are completed (thus 10 measurements). If of those 10 measurements, 2 have a SNR less 1, then the study will be stopped as it is unlikely to meet its 90% target. |
day 1
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Determining the ability to observe differences between benign and cancerous regions
大体时间:day 1
|
The secondary aim of this study is documenting our ability to observe differences between the PASA linear slope values derived from benign and cancerous regions, i.e., to detect the difference of 0.05 of 0.19, 0.17, 0.14, 0.20 dB/MHz between the means of the linear slopes in benign and cancerous regions at the wavelengths of 1220 nm, 1370 nm, 800 nm and 266 nm, respectively. We will aim at differentiating the measurements in benign and cancerous regions at specific wavelengths. We have a null hypothesis for each wavelength that at this specific wavelength, our measurement cannot differentiate the benign and cancerous regions. We will test the hypothesis with paired t-tests. |
day 1
|
合作者和调查者
调查人员
- 首席研究员:Guan Xu, Phd、University of Michigan
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.